Christopher W. Fulton

Array ( [id] => 4251316 [patent_doc_number] => 06222013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Process for esterification of amino' [patent_app_type] => 1 [patent_app_number] => 9/425023 [patent_app_country] => US [patent_app_date] => 1999-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1829 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/222/06222013.pdf [firstpage_image] =>[orig_patent_app_number] => 425023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1355673 [patent_doc_number] => 06576614 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Peptide analogs as irreversible interleukin-1 protease inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/421954 [patent_app_country] => US [patent_app_date] => 1999-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8861 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 604 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576614.pdf [firstpage_image] =>[orig_patent_app_number] => 09421954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631315 [patent_doc_number] => 06635617 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Insulin preparations for pulmonary delivery containing menthol' [patent_app_type] => B1 [patent_app_number] => 09/418778 [patent_app_country] => US [patent_app_date] => 1999-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3534 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635617.pdf [firstpage_image] =>[orig_patent_app_number] => 09418778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384712 [patent_doc_number] => 06294649 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Method of cell inhibition using polypeptides derived from the venom of the Austrialian jumper ant Myrmecia pilosula' [patent_app_type] => 1 [patent_app_number] => 9/269229 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2650 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294649.pdf [firstpage_image] =>[orig_patent_app_number] => 269229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065508 [patent_doc_number] => 06846679 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-25 [patent_title] => 'Characterizing polypeptides through cleavage and mass spectrometry' [patent_app_type] => utility [patent_app_number] => 09/806564 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7569 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846679.pdf [firstpage_image] =>[orig_patent_app_number] => 09806564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631192 [patent_doc_number] => 06635740 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Ligand/lytic peptide compositions and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/381879 [patent_app_country] => US [patent_app_date] => 1999-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15193 [patent_no_of_claims] => 109 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635740.pdf [firstpage_image] =>[orig_patent_app_number] => 09381879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406732 [patent_doc_number] => 06232293 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Method and material for inhibiting complement' [patent_app_type] => 1 [patent_app_number] => 9/398238 [patent_app_country] => US [patent_app_date] => 1999-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 7361 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232293.pdf [firstpage_image] =>[orig_patent_app_number] => 398238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1239993 [patent_doc_number] => 06686335 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-03 [patent_title] => 'Hydroxamate-containing cysteine and serine protease inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/398562 [patent_app_country] => US [patent_app_date] => 1999-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7072 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686335.pdf [firstpage_image] =>[orig_patent_app_number] => 09398562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908304 [patent_doc_number] => 20010011071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'DERIVATIVES OF GLP-1 ANALOGS' [patent_app_type] => new [patent_app_number] => 09/398111 [patent_app_country] => US [patent_app_date] => 1999-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 171148 [patent_no_of_claims] => 238 [patent_no_of_ind_claims] => 112 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011071.pdf [firstpage_image] =>[orig_patent_app_number] => 09398111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440579 [patent_doc_number] => 06495663 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Method and composition for enhancing transport across biological membranes' [patent_app_type] => B1 [patent_app_number] => 09/396195 [patent_app_country] => US [patent_app_date] => 1999-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 23 [patent_no_of_words] => 16621 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495663.pdf [firstpage_image] =>[orig_patent_app_number] => 09396195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1371235 [patent_doc_number] => 06566493 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties' [patent_app_type] => B1 [patent_app_number] => 09/308437 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9539 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566493.pdf [firstpage_image] =>[orig_patent_app_number] => 09308437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575683 [patent_doc_number] => 06469137 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Myelopeptides and their therapeutic use' [patent_app_type] => B1 [patent_app_number] => 09/341173 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3137 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469137.pdf [firstpage_image] =>[orig_patent_app_number] => 09341173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 944196 [patent_doc_number] => 06967250 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-22 [patent_title] => 'Energy transfer dyes' [patent_app_type] => utility [patent_app_number] => 09/386576 [patent_app_country] => US [patent_app_date] => 1999-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8097 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/967/06967250.pdf [firstpage_image] =>[orig_patent_app_number] => 09386576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1203021 [patent_doc_number] => 06720407 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Method for administering insulinotropic peptides' [patent_app_type] => B1 [patent_app_number] => 09/383789 [patent_app_country] => US [patent_app_date] => 1999-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8566 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720407.pdf [firstpage_image] =>[orig_patent_app_number] => 09383789 [rel_patent_id] =>[rel_patent_doc_number] =>)